Epstein-Barr virus vaccine (NIAID)

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameEpstein-Barr virus vaccine (NIAID)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfectious MononucleosisEpstein-Barr Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Inactive CompaniesN/A

Active IndicationsInfectious MononucleosisEpstein-Barr Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A